Epigenetic alteration of microRNAs in DNMT3B-mutated patients of ICF syndrome

Immunodeficiency, Centromeric region instability, Facial anomalies (ICF; OMIM #242860) syndrome, due to mutations in the DNMT3B gene, is characterized by inheritance of aberrant patterns of DNA methylation and heterochromatin defects. Patients show variable agammaglobulinemia and a reduced number of T cells, making them prone to infections and death before adulthood. Other variable symptoms include facial dysmorphism, growth and mental retardation. Despite the recent advances in identifying the dysregulated genes, the molecular mechanisms, which underlie the altered gene expression causing ICF phenotype complexity, are not well understood. Held the recently-shown tight correlation between epigenetics and microRNAs (miRNAs), we searched for miRNAs regulated by DNMT3B activity, comparing cell lines from ICF patients with those from healthy individuals. We observe that eighty-nine miRNAs, some of which involved in immune function, development and neurogenesis, are dysregulated in ICF (LCLs) compared to wild-type cells. Significant DNA hypomethylation of miRNA CpG islands was not observed in cases of miRNA up-regulation in ICF cells, suggesting a more subtle effect of DNMT3B deficiency on their regulation; however, a modification of histone marks, especially H3K27 and H3K4 trimethylation, and H4 acetylation, was observed concomitantly with changes in microRNA expression. Functional correlation between miRNA and mRNA expression of their targets allow us to suppose a regulation either at mRNA level or at protein level. These results provide a better understanding of how DNA methylation and histone code interact to regulate the class of microRNA genes and enable us to predict molecular events possibly contributing to ICF condition.

[1]  K. Basso,et al.  Identification of the human mature B cell miRNome. , 2009, Immunity.

[2]  Curtis Balch,et al.  MicroRNA and mRNA integrated analysis (MMIA): a web tool for examining biological functions of microRNA expression , 2009, Nucleic Acids Res..

[3]  Nectarios Koziris,et al.  DIANA-microT web server: elucidating microRNA functions through target prediction , 2009, Nucleic Acids Res..

[4]  Jane Y. Wu,et al.  Misexpression of miR-196a induces eye anomaly in Xenopus laevis , 2009, Brain Research Bulletin.

[5]  Robert Tibshirani,et al.  Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. , 2008, Blood.

[6]  C. Burge,et al.  Most mammalian mRNAs are conserved targets of microRNAs. , 2008, Genome research.

[7]  J. Penninger,et al.  RANK/RANKL: Regulators of Immune Responses and Bone Physiology , 2008, Annals of the New York Academy of Sciences.

[8]  H. Takayanagi,et al.  The cytokine RANKL produced by positively selected thymocytes fosters medullary thymic epithelial cells that express autoimmune regulator. , 2008, Immunity.

[9]  Megan F. Cole,et al.  Connecting microRNA Genes to the Core Transcriptional Regulatory Circuitry of Embryonic Stem Cells , 2008, Cell.

[10]  Ji Young Kim,et al.  MicroRNA miR-199a* Regulates the MET Proto-oncogene and the Downstream Extracellular Signal-regulated Kinase 2 (ERK2)* , 2008, Journal of Biological Chemistry.

[11]  M. Toyota,et al.  Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. , 2008, Cancer research.

[12]  Qian Tao,et al.  DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function. , 2008, Human molecular genetics.

[13]  T. Patel,et al.  Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes , 2008, Oncogene.

[14]  R. Kuick,et al.  ICF, An Immunodeficiency Syndrome: DNA Methyltransferase 3B Involvement, Chromosome Anomalies, and Gene Dysregulation , 2008, Autoimmunity.

[15]  Doron Betel,et al.  The microRNA.org resource: targets and expression , 2007, Nucleic Acids Res..

[16]  M. D'Esposito,et al.  Chromosome territory reorganization in a human disease with altered DNA methylation , 2007, Proceedings of the National Academy of Sciences.

[17]  Dustin E. Schones,et al.  High-Resolution Profiling of Histone Methylations in the Human Genome , 2007, Cell.

[18]  H. Sültmann,et al.  The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function. , 2007, Cancer research.

[19]  K. Kosik.  The neuronal microRNA system , 2006, Nature Reviews Neuroscience.

[20]  Edwin Cuppen,et al.  Diversity of microRNAs in human and chimpanzee brain , 2006, Nature Genetics.

[21]  Suresh Cuddapah,et al.  The genomic landscape of histone modifications in human T cells , 2006, Proceedings of the National Academy of Sciences.

[22]  Eugene Berezikov,et al.  Many novel mammalian microRNA candidates identified by extensive cloning and RAKE analysis. , 2006, Genome research.

[23]  R. Plasterk,et al.  The diverse functions of microRNAs in animal development and disease. , 2006, Developmental cell.

[24]  Peter A. Jones,et al.  Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. , 2006, Cancer cell.

[25]  E. Li,et al.  Roles for Dnmt3b in mammalian development: a mouse model for the ICF syndrome , 2006, Development.

[26]  Hong Wang,et al.  Secretion of brain‐derived neurotrophic factor from PC12 cells in response to oxidative stress requires autocrine dopamine signaling , 2006, Journal of neurochemistry.

[27]  Stijn van Dongen,et al.  miRBase: microRNA sequences, targets and gene nomenclature , 2005, Nucleic Acids Res..

[28]  E. Miska,et al.  MicroRNA functions in animal development and human disease , 2005, Development.

[29]  D. Gisselsson,et al.  Interphase chromosomal abnormalities and mitotic missegregation of hypomethylated sequences in ICF syndrome cells , 2005, Chromosoma.

[30]  K. Gunsalus,et al.  Combinatorial microRNA target predictions , 2005, Nature Genetics.

[31]  C. Croce,et al.  Impaired T- and B-cell development in Tcl1-deficient mice. , 2005, Blood.

[32]  Eric S. Lander,et al.  Genomic Maps and Comparative Analysis of Histone Modifications in Human and Mouse , 2005, Cell.

[33]  A. Mégarbané,et al.  DNMT3B mutations and DNA methylation defect define two types of ICF syndrome , 2005, Human mutation.

[34]  Y. Goto,et al.  ICF syndrome in a girl with DNA hypomethylation but without detectable DNMT3B mutation , 2004, American journal of medical genetics. Part A.

[35]  K. Robertson,et al.  DNMT3B interacts with hSNF2H chromatin remodeling enzyme, HDACs 1 and 2, and components of the histone methylation system. , 2004, Biochemical and biophysical research communications.

[36]  Keith D Robertson,et al.  Isolation and characterization of a novel DNA methyltransferase complex linking DNMT3B with components of the mitotic chromosome condensation machinery. , 2004, Nucleic acids research.

[37]  M. Milili,et al.  Defective B-cell-negative selection and terminal differentiation in the ICF syndrome. , 2004, Blood.

[38]  B. Rollins,et al.  DNA methyltransferase 3b contributes to oncogenic transformation induced by SV40T antigen and activated Ras , 2003, Oncogene.

[39]  K. Rajewsky,et al.  Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1 , 2003, Nature Immunology.

[40]  M. D'Esposito,et al.  Allelic inactivation of the pseudoautosomal gene SYBL1 is controlled by epigenetic mechanisms common to the X and Y chromosomes. , 2002, Human molecular genetics.

[41]  Y. Fukushima,et al.  Three novel DNMT3B mutations in Japanese patients with ICF syndrome. , 2002, American journal of medical genetics.

[42]  Albert Jeltsch,et al.  Molecular Enzymology of the Catalytic Domains of the Dnmt3a and Dnmt3b DNA Methyltransferases* 210 , 2002, The Journal of Biological Chemistry.

[43]  David E. Misek,et al.  DNA methyltransferase 3B mutations linked to the ICF syndrome cause dysregulation of lymphogenesis genes. , 2001, Human molecular genetics.

[44]  N. Dillon,et al.  Binding of Ikaros to the λ5 promoter silences transcription through a mechanism that does not require heterochromatin formation , 2001, The EMBO journal.

[45]  S. Gasser,et al.  Positions of Potential:Nuclear Organization and Gene Expression , 2001, Cell.

[46]  C. Wijmenga,et al.  Genetic variation in ICF syndrome: Evidence for genetic heterogeneity , 2000, Human mutation.

[47]  C. Wijmenga,et al.  The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[48]  N. Tommerup,et al.  Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene , 1999, Nature.

[49]  D. Haber,et al.  DNA Methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Methylation and Mammalian Development , 1999, Cell.

[50]  A. Fisher,et al.  Dynamic repositioning of genes in the nucleus of lymphocytes preparing for cell division. , 1999, Molecular cell.

[51]  L. E. McDonald,et al.  A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[52]  M. Esteller,et al.  DNA methylomes, histone codes and miRNAs: tying it all together. , 2009, The international journal of biochemistry & cell biology.

[53]  Y. Pekarsky,et al.  Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. , 2006, Cancer research.